The progression from single to dual to triple agonism has produced measurable advances in clinical research outcomes, and the category continues to evolve as additional compounds enter clinical development
If you are a current ExactCare patient and need help, call 1-877-355-7225
Chem Res Toxicol 21:117128 Jordan A, Haidacher S, Hanel G, Hartungen E, Herbig J, Maerk L, Schottkowsky R, Seehauser H, Sulzer P, Maerk TD (2009) An online ultra-high sensitivity proton-transfer-reaction mass-spectrometer combined with switchable reagent ion capability (PTR+SRI-MS)
Male C57BL/6 and leptin-deficient ob/ob mice (with exons 2 and 3 of the leptin gene deleted) were obtained from Biocytogen Pharmaceuticals (Beijing, China)